• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·UK·Healthcare·DOC.AX
Share

Doctor Care Anywhere Group PLC Stocks

A$ 0.12Last Updated 24.08.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

A$ 31.57M

A$ 0.12
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom and the Republic of Ireland. It offers services in the areas of medical letters, imaging support, blood testing, and mental health support, as well as comprehensive health assessments, health solutions, specialist care pathways, physiotherapy support, and GP and ACP appointments. The company provides treatments for allergies, intolerances, colds, flu, minor illnesses, gut health, joint, muscles, lifestyle support, men’s and women’s health, mental health, sexual health, and skin conditions. Doctor Care Anywhere Group PLC was founded in 2013 and is headquartered in Mayfair, the United Kingdom.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Very favourable
7/7

The average target price of DOC.AX is 0.22 and suggests 81.6% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

25.08.2026 03:44

Trump has threatened Canada with new 50% tariffs. Who stands to lose?

25.08.2026 02:34

Nebius Raised $5.75 Billion for Data Centers and AI Through a Bond Offering

25.08.2026 01:33

The Ministry of Finance did not make any new promises to the market regarding the buyback of government debt. Will its $1 trillion in reserves help?

24.08.2026 23:52

Insiders bought $15 million worth of Alibaba stock after the crash. Should you follow their lead?

24.08.2026 23:04

"The Qualcomm Challenge": What Does Xiaomi's Release of Its Own New Mobile Processor Mean?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026